Citation Impact
Citing Papers
Colorectal cancer statistics, 2014
2014 Standout
Colorectal cancer statistics, 2023
2023 Standout
Cancer treatment and survivorship statistics, 2022
2022 Standout
The integration of cytotoxics and biologicals in the treatment of metastatic colorectal cancer
2007
Treatment Decisions After Diagnosis of Metastatic Colorectal Cancer
2011
Identification, Characterization, and Crystal Structure of the Omega Class Glutathione Transferases
2000
Health effects of quercetin: From antioxidant to nutraceutical
2008 Standout
Survival and disease-progression benefits with treatment regimens for advanced colorectal cancer: a meta-analysis
2007
AZT and emodin exhibit synergistic growth-inhibitory effects on K562/ADM cells by inducing S phase cell cycle arrest and suppressing MDR1 mRNA/p-gp protein expression
2013
R1 Resection by Necessity for Colorectal Liver Metastases
2008
Silver Nanoparticles Synthesized Using Carica papaya Leaf Extract (AgNPs-PLE) Causes Cell Cycle Arrest and Apoptosis in Human Prostate (DU145) Cancer Cells
2020 Standout
Chemotherapy-Induced Ca2+ Release Stimulates Breast Cancer Stem Cell Enrichment
2017 StandoutNobel
Applications of CRISPR-Cas Enzymes in Cancer Therapeutics and Detection
2018 StandoutNobel
Myeloid-derived suppressor cells in the era of increasing myeloid cell diversity
2021 Standout
Cetuximab and Chemotherapy as Initial Treatment for Metastatic Colorectal Cancer
2009 Standout
Chemotherapy-Associated Hepatotoxicity: Do We Need to Be Concerned?
2009
Elevated C-Reactive Protein and Hypoalbuminemia Measured before Resection of Colorectal Liver Metastases Predict Postoperative Survival
2010
Checking consistency in mixed treatment comparison meta‐analysis
2010 Standout
Colorectal cancer
2019 Standout
Pyroptosis: mechanisms and diseases
2021 Standout
Gut microbiota modulation of chemotherapy efficacy and toxicity
2017 Standout
Oxaliplatin: a review of approved uses
2011
Randomized phase II study of irinotecan, leucovorin and 5-fluorouracil (ILF) versus cisplatin plus ILF (PILF) combination chemotherapy for advanced gastric cancer
2007
Mitoxantrone-Induced Suicidal Erythrocyte Death
2014
A National Cancer Institute of Canada Clinical Trials Group Study – IND.135: Phase I/II study of irinotecan (camptosar), oxaliplatin and raltitrexed (tomudex) (COT) in patients with advanced colorectal cancer
2005
Systemic inflammatory response predicts postoperative outcome in patients with liver metastases from colorectal cancer
2009
Hypoxia-inducible factors promote breast cancer stem cell specification and maintenance in response to hypoxia or cytotoxic chemotherapy
2018 StandoutNobel
Intracellular Antioxidants: from Chemical to Biochemical Mechanisms
1999
Fusobacterium nucleatum Promotes Colorectal Carcinogenesis by Modulating E-Cadherin/β-Catenin Signaling via its FadA Adhesin
2013 Standout
Summary of current therapeutic options for peritoneal metastases from colorectal cancer
2012
The systemic inflammation-based neutrophil–lymphocyte ratio: Experience in patients with cancer
2013 Standout
Quantitative reactivity profiling predicts functional cysteines in proteomes
2010 StandoutNatureNobel
Cisplatin in cancer therapy: Molecular mechanisms of action
2014 Standout
Oxaliplatin, irinotecan and capecitabine as first-line therapy in metastatic colorectal cancer (mCRC): a dose-finding study and pharmacogenomic analysis
2010
Racial Disparity in Consultation, Treatment, and the Impact on Survival in Metastatic Colorectal Cancer
2013
Antimicrobial strategies centered around reactive oxygen species – bactericidal antibiotics, photodynamic therapy, and beyond
2013 Standout
Fusobacterium nucleatum Promotes Chemoresistance to Colorectal Cancer by Modulating Autophagy
2017 Standout
Colorectal cancer
2015
The status of platinum anticancer drugs in the clinic and in clinical trials
2010 Standout
VEGF in Signaling and Disease: Beyond Discovery and Development
2019 Standout
Vitamin supplementation does not protect against symptoms in ozone-responsive subjects
2005
The Clavien-Dindo Classification of Surgical Complications
2009 Standout
The systemic inflammation-based Glasgow Prognostic Score: A decade of experience in patients with cancer
2012 Standout
Mechanisms and pathophysiological significance of eryptosis, the suicidal erythrocyte death
2015 Standout
Combined colonic cancer treatment with vitamin D analogs and irinotecan or oxaliplatin.
2013
The side effects of platinum-based chemotherapy drugs: a review for chemists
2018 Standout
Aloe‐emodin: A review of its pharmacology, toxicity, and pharmacokinetics
2019 Standout
Antioxidant supplements for prevention of mortality in healthy participants and patients with various diseases
2012 Standout
Neutrophil extracellular traps sequester circulating tumor cells via β1-integrin mediated interactions
2017
Liposomal Formulations in Clinical Use: An Updated Review
2017 Standout
Chemotherapy for advanced gastric cancer
2017 Standout
Emodin: A Review of its Pharmacology, Toxicity and Pharmacokinetics
2016 Standout
GLUTATHIONE TRANSFERASES
2004 Standout
Preoperative neutrophil to lymphocyte ratio as a prognostic predictor after curative resection for non-small cell lung cancer.
2011
Systemic cancer therapy: achievements and challenges that lie ahead
2013
Hyperthermic Intraperitoneal Chemotherapy in Ovarian Cancer
2018 Standout
Phase II Trial of Infusional Fluorouracil, Irinotecan, and Bevacizumab for Metastatic Colorectal Cancer: Efficacy and Circulating Angiogenic Biomarkers Associated With Therapeutic Resistance
2009
Systematic review: the role of the gut microbiota in chemotherapy‐ or radiation‐induced gastrointestinal mucositis – current evidence and potential clinical applications
2014
Can metastatic colorectal cancer be cured?
2012
“Inverse Drug Discovery” Strategy To Identify Proteins That Are Targeted by Latent Electrophiles As Exemplified by Aryl Fluorosulfates
2017 StandoutNobel
Diagnosis and Treatment of Metastatic Colorectal Cancer
2021
Works of M. Andreuccetti being referenced
Localization of a GSH-Dependent Dehydroascorbate Reductase in Rat Tissues and Subcellular Fractions
1996
A multicenter phase II study of the combination of oxaliplatin, irinotecan and capecitabine in the first-line treatment of metastatic colorectal cancer
2009
First-line treatment of metastatic colorectal cancer with irinotecan, oxaliplatin and 5-fluorouracil/leucovorin (FOLFOXIRI): results of a phase II study with a simplified biweekly schedule
2004
Azidothymidine in combination with 5-fluorouracil in human colorectal cell lines: In vitro synergistic cytotoxicity and dna-induced strand-breaks
1996
Phase II study of sequential chemotherapy with docetaxel–estramustine followed by mitoxantrone–prednisone in patients with advanced hormone-refractory prostate cancer
2007
Baseline elevated leukocyte count in peripheral blood is associated with poor survival in patients with advanced non-small cell lung cancer: a prognostic model
2008
Randomized Trial of Two Induction Chemotherapy Regimens in Metastatic Colorectal Cancer: An Updated Analysis
2010
Long-Term Outcome of Initially Unresectable Metastatic Colorectal Cancer Patients Treated with 5-Fluorouracil/Leucovorin, Oxaliplatin, and Irinotecan (FOLFOXIRI) Followed by Radical Surgery of Metastases
2009
Surgical resection of metastases (mts) after biweekly chemotherapy with irinotecan, oxaliplatin and 5-fluorouracil/leucovorin (FOLFOXIRI) in initially unresectable metastatic colorectal cancer (MCRC)
2004
Phase III Trial of Infusional Fluorouracil, Leucovorin, Oxaliplatin, and Irinotecan (FOLFOXIRI) Compared With Infusional Fluorouracil, Leucovorin, and Irinotecan (FOLFIRI) As First-Line Treatment for Metastatic Colorectal Cancer: The Gruppo Oncologico Nord Ovest
2007